Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Penel

Showing results (101-110 of 350) with videos related to

Pageof 35
Sort By:
Bulletin Du Cancer|June 7, 2025
[Evaluation of our management circuit for immune-related adverse events in patients with non-metastatic triple-negative breast cancer]Géraldine Rosier, Nicolas Penel, Audrey Mailliez, et al.
Critical Reviews in Oncology/Hematology|September 9, 2019
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosisDiane Pannier, Abel Cordoba, Thomas Ryckewaert, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2021
Two cases of rare late onset life-threatening pseudoprogression with immune check point inhibitors in advanced cancer patients - a case reportValentin Coudert, Yves-Marie Robin, Williams Tessier, et al.
BMC Cancer|August 14, 2013
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic reviewSheetal Sharma, Shweta Takyar, Stephanie C Manson, et al.
Melanoma Research|March 7, 2020
Symptomatic acute hypotension associated with high-dose dacarbazinePierre-Yves Cren, Guillaume Marliot, Diane Pannier, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2011
Advanced Abrikossoff tumour: a metastatic or a multifocal malignancy?Ingrid Fumagalli, Nicolas Penel, Agnès Wacrenier, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 2010
Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamideClothilde Lindet, Marie Vanhuyse, Estelle Thebaud, et al.
Investigational New Drugs|January 10, 2009
"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agentsNicolas Penel, Nicolas Isambert, Pierre Leblond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2007
Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysisNicolas Penel, Sylvain Dewas, Philippe Doutrelant, et al.
Critical Reviews in Oncology/Hematology|June 17, 2019
Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disordersArnaud Jannin, Nicolas Penel, Miriam Ladsous, et al.
Pageof 35

Showing results (101-110 of 350) with videos related to

Sort By:
Pageof 35
Bulletin Du Cancer|June 7, 2025
[Evaluation of our management circuit for immune-related adverse events in patients with non-metastatic triple-negative breast cancer]Géraldine Rosier, Nicolas Penel, Audrey Mailliez, et al.
Critical Reviews in Oncology/Hematology|September 9, 2019
Hormonal therapies in uterine sarcomas, aggressive angiomyxoma, and desmoid-type fibromatosisDiane Pannier, Abel Cordoba, Thomas Ryckewaert, et al.
Acta Oncologica (Stockholm, Sweden)|February 15, 2021
Two cases of rare late onset life-threatening pseudoprogression with immune check point inhibitors in advanced cancer patients - a case reportValentin Coudert, Yves-Marie Robin, Williams Tessier, et al.
BMC Cancer|August 14, 2013
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic reviewSheetal Sharma, Shweta Takyar, Stephanie C Manson, et al.
Melanoma Research|March 7, 2020
Symptomatic acute hypotension associated with high-dose dacarbazinePierre-Yves Cren, Guillaume Marliot, Diane Pannier, et al.
Acta Oncologica (Stockholm, Sweden)|July 13, 2011
Advanced Abrikossoff tumour: a metastatic or a multifocal malignancy?Ingrid Fumagalli, Nicolas Penel, Agnès Wacrenier, et al.
Acta Oncologica (Stockholm, Sweden)|July 31, 2010
Pulmonary blastoma in adult: dramatic but transient response to doxorubicin plus ifosfamideClothilde Lindet, Marie Vanhuyse, Estelle Thebaud, et al.
Investigational New Drugs|January 10, 2009
"Classical 3 + 3 design" versus "accelerated titration designs": analysis of 270 phase 1 trials investigating anti-cancer agentsNicolas Penel, Nicolas Isambert, Pierre Leblond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 22, 2007
Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysisNicolas Penel, Sylvain Dewas, Philippe Doutrelant, et al.
Critical Reviews in Oncology/Hematology|June 17, 2019
Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disordersArnaud Jannin, Nicolas Penel, Miriam Ladsous, et al.
Pageof 35